Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Details
Original language | English |
---|---|
Pages (from-to) | e39-e42 |
Journal | Haematologica |
Volume | 102 |
Issue number | 2 |
Publication status | Published - Feb 2017 |
Peer-reviewed | Yes |
External IDs
Scopus | 85011601383 |
---|---|
PubMed | 27856510 |
PubMedCentral | PMC5286951 |
ORCID | /0000-0002-2524-1199/work/142251486 |
Keywords
Keywords
- Adolescent, Antineoplastic Agents/therapeutic use, Child, Child, Preschool, Drug Administration Schedule, Female, Fusion Proteins, bcr-abl/antagonists & inhibitors, Gene Expression, Germany, Humans, Imatinib Mesylate/therapeutic use, Infant, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy, Male, Protein Kinase Inhibitors/therapeutic use, RNA, Messenger/antagonists & inhibitors, Treatment Outcome